Posting slower-than-expected revenue growth, flash software maker Adobe Systems Incorporated has announced it would be laying off hundreds of workers in the U.S. and Europe. The news isn’t quite so bleak for New York software developer Altair, who has nearly 600 open positions advertised on its website.
The Wall Street Journal reports that the California-based Adobe said it would be cutting as many as 750 jobs in order to better concentrate on its digital media and digital marketing departments.
Adobe said the restructuring also included a bigger investment in its web formatting called HTML5, rather than its popular Adobe Flash player.
Meanwhile, the Troy, New York-based simulation software maker Altair is looking to fill hundreds of jobs at its headquarters and other offices around the world, according to MLive.com.
The company said it was having trouble finding qualified workers with technical degrees. Altair said it recently held 10 job fairs with a focus on hiring talented students, mostly from master’s degree programs. The company also announced a new internship program, which is set to get underway next summer.

read more

Ohio officials are hoping that a multi-million award to the biotechnology industry will help boost innovation and education in order to create more jobs in the field. The move comes in the wake of a new report that second quarter earnings for the sector rose despite a stalled economic rebound.
The Ohio Third Frontier recently announced the award package that will go toward state healthcare and biotechnology programs to accelerate growth in the biomedical and medical imaging fields.
Under the initiative, the biomedial and imaging sector will receive $8 million including almost $1 million to the Cleveland-based Arteriocyte Incorporated, which is working with Ohio State University to develop stem cell expansion for clinical applications, and the West Chester-based ArtiCure Incorporated, which was given $1 million to make and market clips used in open heart surgery.
Financial analysts said that the biotechnology field is proving to be a top performer on Wall Street after some top stocks fell on news of deflated sales.
The Record reports that overall stocks fell an average of 0.4 percent in the second quarter of this year, while biotechnology and healthcare stocks saw an average gain of 7.3 percent during the same time period.

read more